Filing Flows › Cumberland Pharmaceuticals (CPIX) › How it makes money
How Cumberland Pharmaceuticals (CPIX) makes money
Cumberland Pharmaceuticals (CPIX) made $8.8M of revenue in the second quarter 2026 (Q2 2026), -19% from a year earlier. Talicia brought in $2.3M (27%); Sancuso brought in $1.8M (21%); Vibativ brought in $1.7M (20%).
Drawing the Sankey…
Revenue by segment, Q2 2026
| Segment | Revenue | Share | Q/Q | Y/Y |
|---|---|---|---|---|
| Talicia | $2.3M | 26.7% | +23% | — |
| Sancuso | $1.8M | 20.6% | -38% | -42% |
| Vibativ | $1.7M | 19.8% | -18% | -36% |
| Caldolor | $1.5M | 16.8% | +53% | -7% |
| Kristalose | $1.1M | 12.1% | +8% | -61% |
| Other revenue | $222K | 2.5% | +31% | -55% |
| Acetadote | $137K | 1.6% | +163% | -29% |
Where each dollar of revenue goes
| Line | Q2 2026 | % of revenue |
|---|---|---|
| Revenue | $8.8M | 100.0% |
| Income tax | $4K | 0.0% |
| Operating cash flow | $169K | 1.9% |
| Free cash flow | $130K | 1.5% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q2 2026 | $8.8M | -19% |
| Q1 2026 | $9.1M | -22% |
| Q4 2025 | $13.7M | +31% |
| Q3 2025 | $8.3M | -9% |
| Q2 2025 | $10.8M | +10% |
| Q1 2025 | $11.7M | +38% |
| Q4 2024 | $10.4M | +12% |
From Cumberland Pharmaceuticals' 10-Q filed Aug 7, 2026 (on EDGAR).
Questions
How does Cumberland Pharmaceuticals make money?
Cumberland Pharmaceuticals (CPIX) made $8.8M of revenue in the second quarter 2026 (Q2 2026), -19% from a year earlier. Talicia brought in $2.3M (27%); Sancuso brought in $1.8M (21%); Vibativ brought in $1.7M (20%).
What is Cumberland Pharmaceuticals' biggest business?
Talicia: $2.3M in the second quarter 2026, 27% of revenue.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.